Table 2 Primary and secondary outcomes according to dexamethasone administration
POD 1 | POD 3 | |||||
|---|---|---|---|---|---|---|
Control (n = 19) | Dexamethasone (n = 19) | p | Control (n = 19) | Dexamethasone (n = 19) | p | |
Epidural PCA (mL) | 63.6 [55.9–72.7] | 68.5 [60.2–89.0] | 0.281 | 199.4 [172.4–225.1] | 194.7 [169.1–252.2] | 0.890 |
NRS | ||||||
Rest | 3.0 [1.4–4.0] | 3.0 [1.0–4.5] | 0.975 | 2 [1.5–3.0] | 2 [1.0–2.5] | 0.549 |
Cough | 3.0 [3.0–8.0] | 3.8 [3.0–5.8] | 0.781 | 3.0 [3.0–6.0] | 3.0 [2.0–5.0] | 0.369 |
Shoulder pain | 5 (26.32%) | 2 (10.53%) | 0.405 | 4 (21.05%) | 3 (15.79%) | 1.000 |
Rescue drug (mg) | 10 [10–20] | 10 [10–20] | 0.453 | 2.5 [0–26] | 2.5 [0–19] | 0.862 |
Nausea | 2 (10.53%) | 2 (10.53%) | 1.000 | 1 (5.26%) | 1 (5.26%) | 1.000 |
Vomiting | 0 (0%) | 1 (5.26%) | 1.000 | 0 (0%) | 0 (0%) | 1.000 |